EFFECTIVENESS OF EFGARTIGIMOD IN PATIENT WITH MYASTHENIA GRAVIS AND TUMOR: A SINGLE CENTER EXPERIENCE

被引：0
|
作者：
Ruan, Zhe
Chang, Ting
Hao, Sijia
Gao, Ting
Tang, Yonglan
Huang, Xiaoxi
Cao, Xiangqi
机构：
来源：
MUSCLE & NERVE | 2024年 / 70卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
261
引用
收藏
页码：588 / 588
页数：1
相关论文
共 50 条
  • [1] Efgartigimod in AChR and non-AChR generalized myasthenia gravis: a single center experience
    Antozzi, C.
    Frangiamore, R.
    Rinaldi, E.
    Vanoli, F.
    Bonanno, S.
    Maggi, L.
    Mantegazza, R.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [2] Individualized Dosing of Efgartigimod in Patients With Generalized Myasthenia Gravis: Clinical Experience at a Single Center
    Silvestri, Nicholas J.
    MUSCLE & NERVE, 2025, 71 (03) : 422 - 428
  • [3] A real world experience with Efgartigimod in generalized Myasthenia Gravis in a national reference center
    Antozzi, C.
    Frangiamore, R.
    Rinaldi, E.
    Vanoli, F.
    Andreetta, F.
    Ciusani, E.
    Bonanno, S.
    Maggi, L.
    Gallone, A.
    Pinna, A.
    Mantegazza, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 204 - 204
  • [4] The effectiveness and value of eculizumab and efgartigimod for generalized myasthenia gravis
    Tice, Jeffrey A.
    Touchette, Daniel R.
    Lien, Pei-Wen
    Agboola, Foluso
    Nikitin, Dmitriy
    Pearson, Steven D.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (01): : 119 - 124
  • [5] Efgartigimod in generalized myasthenia gravis: A real-life experience at a national reference center
    Frangiamore, Rita
    Rinaldi, Elena
    Vanoli, Fiammetta
    Andreetta, Francesca
    Ciusani, Emilio
    Bonanno, Silvia
    Maggi, Lorenzo
    Gallone, Annamaria
    Colasuonno, Anna
    Tramacere, Irene
    Cheli, Marta
    Pinna, Alessandro
    Mantegazza, Renato
    Antozzi, Carlo
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (04)
  • [6] Ravulizumab and Efgartigimod in Myasthenia Gravis
    Stascheit, Frauke
    Sousa, Carla Daiane Ferreira de
    Aigner, Annette
    Behrens, Malina
    Keller, Christian W.
    Klotz, Luisa
    Lehnerer, Sophie
    Stein, Maike
    Herdick, Meret
    Doksani, Paolo
    Gerischer, Lea M.
    Hoffmann, Sarah
    Lazaridis, Konstantinos
    Tzartos, John
    Wiendl, Heinz
    Meisel, Andreas
    Luenemann, Jan D.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2025, 12 (01):
  • [7] Real-World experience with efgartigimod in patients with myasthenia gravis
    Fuchs, Lior
    Shelly, Shahar
    Vigiser, Ifat
    Kolb, Hadar
    Regev, Keren
    Schwartzmann, Yoel
    Vaknin-Dembinsky, Adi
    Dori, Amir
    Karni, Arnon
    JOURNAL OF NEUROLOGY, 2024, 271 (06) : 3462 - 3470
  • [8] Abdeg technology for the treatment of myasthenia gravis: efgartigimod drug experience
    Ribeiro Dos Santos, Jessica Barreto
    Gomes, Rosangela Maria
    Ribeiro da Silva, Michael Ruberson
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2022, 18 (09) : 879 - 888
  • [9] Single institution experience with efgartigimod in patients with myasthenia gravis: Patient selection, dosing schedules, treatment response, and adverse events
    Singer, Madeline
    Khella, Sami
    Bird, Shawn
    McIntosh, Paul
    Paudyal, Bandhu
    Wadhwani, Anil
    Quinn, Colin
    Karam, Chafic
    MUSCLE & NERVE, 2024, 69 (01) : 87 - 92
  • [10] Efgartigimod treatment for generalized myasthenia gravis: a single-center case series of 16 patients
    Nomura, Toshiya
    Imamura, Michie
    Imura, Masao
    Mizutani, Hironori
    Ueda, Mitsuharu
    FRONTIERS IN NEUROLOGY, 2024, 15
12345